Great Point closes $215 million buyout fund

Great Point Partners, a Greenwich-based health care investment firm focused on growth investing, has closed Great Point Partners II, LP, a $215 million growth buyout fund. This new fund is larger than the firm’s prior fund, GPP I which was $156 million and
exceeds the firm’s $200 million fund raising target. GPP II, like Great Point’s prior fund will invest in lower middle market, growth health care companies.
“This successful fundraise was driven by strong support from both existing and new investors in the United States, the United Kingdom and continental Europe, said Dr. Jeffrey Jay, managing director of Great Point Partners, in prepared comments. “We see this success as a clear global endorsement by our investors of our growth buy‐out and growth recapitalization investing model.”
GPP II’s Limited Partners include endowments, foundations, family offices, banks and pension funds. A significant number of the new investors are from outside of the United States.
“GPP II will continue to pursue a strategy the firm has followed for a decade partnering with management teams to build marketleading health care companies through a combination of organic growth and the aggressive pursuit of accretive tuck‐in
acquisitions. While growth is always a core aspect of our investment theses, we add value by placing members of our CEO Advisory Board as operating chairmen or lead directors on portfolio company boards and by assigning a team to research, source and close tuck‐in acquisitions,” Managing Director Adam Dolder said in prepared comments.